CARREL MICHAEL H 4

What Happened Michael H. Carrel, President, CEO and Director of AtriCure, acquired 636 shares of AtriCure common stock on June 30, 2026. The shares were purchased under the company's 2018 Employee Stock Purchase Plan (ESPP) at $23.78 per share, for a total reported value of $15,124. This was a purchase (acquisition) rather than a sale.

Key Details

• Transaction date: 2026-06-30; Filing date: 2026-07-02 (filed timely with the SEC).
• Price: $23.78 per share; Total value: $15,124.
• Shares acquired: 636 shares.
• Shares owned after transaction: Not disclosed in the Form 4 filing.
• Footnotes: Shares purchased pursuant to the AtriCure 2018 ESPP. Purchase price reflects 85% of the closing price on 6/30/2026 (closing price $27.98). Reporting person disclaims beneficial ownership except for pecuniary interest.

Context This was an ESPP purchase — a routine employee-plan acquisition that provides a discounted entry price (here 85% of the closing price). ESPP purchases are generally considered a form of employee participation and can be viewed positively, though they are common and do not necessarily signal an active trading decision by a CEO. The filing was submitted within the normal Form 4 reporting window.